Skip to main content

Advertisement

Log in

Possible autoimmune hepatitis induced after chronic active Epstein−Barr virus infection

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Chronic active Epstein−Barr virus infection (CAEBV) can be manifested in a variety of systemic conditions, including interstitial pneumonia, malignant lymphoma, and coronary aneurysm. Sometimes it may be associated with hepatic failure, although the mechanism underlying CAEBV-related hepatotoxicity remains unclear. We encountered a case of autoimmune hepatitis (AIH) associated with CAEBV. A 61-year-old male was referred to our hospital because of abnormal liver enzyme levels after initial diagnosis of CAEBV had been made by laboratory tests and liver biopsy. On admission, positivity for anti-nuclear antibody was evident, and examination of the liver biopsy specimen showed findings compatible with AIH. Steroid administration was initiated, and the liver function parameters subsequently improved. Although phenotypic changes in liver biopsy specimens are rare in this condition, the present case could provide clues to the possible pathogenesis of AIH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

CAEBV:

Chronic active Epstein−Barr virus infection

AIH:

Autoimmune hepatitis

ANA:

Anti-nuclear antibody

References

  1. Rickinson AB. Chronic, symptomatic Epstein–Barr virus-infections. Immunol Today. 1986;7:13–4.

    Article  Google Scholar 

  2. Ohshima K, Suzumiya J, Sugihara M, et al. Clinicopathological study of severe chronic active Epstein–Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome. Pathol Int. 1998;48:934–43.

    Article  CAS  PubMed  Google Scholar 

  3. Okano M, Matsumoto S, Osato T, et al. Severe chronic active Epstein–Barr-virus infection syndrome. Clin Microbiol Rev. 1991;4:129–35.

    CAS  PubMed Central  PubMed  Google Scholar 

  4. Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein–Barr virus infection. J Infect Dis. 2003;187:527–33.

    Article  PubMed  Google Scholar 

  5. Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein–Barr virus infection. Blood. 2001;98:280–6.

    Article  CAS  PubMed  Google Scholar 

  6. Kimura H, Morita M, Yabuta Y, et al. Quantitative analysis of Epstein–Barr virus load by using a real-time PCR assay. J Clin Microbiol. 1999;37:132–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  7. Alvarez E, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.

    Article  CAS  PubMed  Google Scholar 

  8. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.

    Article  PubMed  Google Scholar 

  9. Krawitt EL. Medical progress: autoimmune hepatitis. N Engl J Med. 2006;354:54–66.

    Article  CAS  PubMed  Google Scholar 

  10. Vento S, Guella L, Mirandola F, et al. Epstein–Barr-virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet. 1995;346:608–9.

    Article  CAS  PubMed  Google Scholar 

  11. Vento S, Garofano T, Diperri G, et al. Identification of hepatitis-a virus as a trigger for autoimmune chronic hepatitis type-1 in susceptible individuals. Lancet. 1991;337:1183–7.

    Article  CAS  PubMed  Google Scholar 

  12. Huppertz HI, Treichel U, Gassel AM, et al. Autoimmune hepatitis following hepatitis-a virus-infection. J Hepatol. 1995;23:204–8.

    Article  CAS  PubMed  Google Scholar 

  13. Wucherpfennig KW. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest. 2001;108:1097–104.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein–Barr virus infection. Am J Hematol. 2005;80:64–9.

    Article  PubMed  Google Scholar 

Download references

Disclosures

Conflict of Interest:

Yoshiko Wada, Chikako Sato, Kyoko Tomita, Rika Ishii-Aso, Hiroaki Haga, Kazuo Okumoto, Yuko Nishise, Hisayoshi Watanabe, Tadasih Togashi, Yoshiyuki Ueno declare that they have no conflict of interest.

Human/Animal Rights:

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008(5).

Informed Consent:

Informed consent was obtained from all patients for being included in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyoko Tomita.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wada, Y., Sato, C., Tomita, K. et al. Possible autoimmune hepatitis induced after chronic active Epstein−Barr virus infection. Clin J Gastroenterol 7, 58–61 (2014). https://doi.org/10.1007/s12328-013-0438-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-013-0438-2

Keywords

Navigation